About · Author
David Ruderman
David Ruderman is the founder of ResearchPay. He writes the guides on this site about payment processing for research-use-only peptide merchants.
Why did David start ResearchPay?
Research peptide sellers are routinely approved by general-purpose platforms and then shut down, or pushed toward setups that misdescribe the business. ResearchPay takes the slower route: applications that disclose exactly what is sold, placed with banks that accept the category, and supported after go-live.
What has David written?
- Peptide payment processing: the complete guide
- Research chemical payment processing
- Rates: retail and wholesale ranges
- How to accept credit cards for research peptides
- RUO website checklist
- Does Stripe allow peptides?
- Account frozen? The first 72 hours
- B2B vs B2C processing rates
- Chargeback thresholds: Visa VAMP and Mastercard ECM
ResearchPay works only with products sold for research use only, not for human or animal use. This page is general information, not legal advice. Approval, pricing, reserves and limits are set by the acquiring bank and are subject to underwriting.